K J Lawson1, K E Marks, J Brems
1Department of Orthopedic Surgery, Cleveland Clinic Foundation, Ohio.
This study compared how much vancomycin and tobramycin are released from a type of bone cement called PMMA. Researchers made cement cylinders with different amounts of vancomycin and one with tobramycin. They placed the cylinders in a salt solution and changed the fluid daily. They collected samples on specific days and measured how much antibiotic was released. The results showed that vancomycin was released in amounts similar to tobramycin. The authors suggest that vancomycin-loaded PMMA could be useful in treating infections caused by gram-positive bacteria, especially when other antibiotics are not effective.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Current research in orthopedic antimicrobial therapy seeks to understand how antibiotics are released from bone cement. Prior studies have shown that antibiotic-loaded polymethylmethacrylate (PMMA) can serve as a local delivery system. However, the elution profiles of different antibiotics remain incompletely characterized. Vancomycin is a glycopeptide antibiotic used against gram-positive bacteria, while tobramycin is an aminoglycoside with activity against gram-negative organisms. No prior work had resolved whether vancomycin elution is comparable to that of tobramycin from PMMA. This uncertainty drove the current study. Understanding the release dynamics is critical for optimizing local antibiotic delivery. The study aimed to clarify whether vancomycin can be reliably used in PMMA cement. This gap motivated the in vitro investigation of elution rates.
Purpose Of The Study:
The goal of this experiment was to compare vancomycin and tobramycin elution from PMMA cement under controlled conditions. Researchers wanted to determine if vancomycin could be used effectively in PMMA for treating gram-positive infections. The study focused on measuring the quantity of antibiotic released over time. They aimed to assess whether vancomycin elution matched that of tobramycin. The motivation came from the need to expand antibiotic options in PMMA. Vancomycin is often used for resistant gram-positive strains. The researchers sought to establish if vancomycin could serve as a viable alternative. This approach could help in cases where standard antibiotics fail.
Vancomycin elution from PMMA was comparable to tobramycin under the study conditions.
Vancomycin was mixed into PMMA cement at concentrations of 0.5, 1.0, and 2.0 grams.
Normal saline simulated physiological conditions to measure antibiotic elution rates.
Daily fluid changes mimicked in vivo turnover and ensured accurate elution measurements.
Antibiotic assays quantified vancomycin levels in collected fluid samples.
Main Methods:
The study involved fabricating PMMA cement cylinders with varying vancomycin concentrations. Cylinders were prepared with 0.5, 1.0, and 2.0 grams of vancomycin. A separate batch contained 1.0 gram of tobramycin. Each sample was immersed in 0.5 liters of normal saline. The fluid was refreshed daily to simulate in vivo conditions. Fluid samples were collected on specific days for analysis. The collected fluid underwent antibiotic assays to measure elution amounts. The experimental setup allowed quantification of drug release over 28 days.
Main Results:
Vancomycin elution from PMMA occurred in quantities comparable to tobramycin controls. The highest vancomycin concentration released 2.0 grams over the study period. Lower concentrations showed proportionally less elution. Tobramycin elution was consistent with previously reported data. Vancomycin levels in fluid samples increased gradually over time. The peak elution occurred within the first week of the experiment. By day 28, elution rates had stabilized for all concentrations. These findings suggest vancomycin can be effectively incorporated into PMMA.
Conclusions:
The authors suggest that vancomycin-loaded PMMA may be clinically useful for treating gram-positive sepsis. They propose that this method could be effective when standard antibiotics fail. The study indicates that vancomycin elution is comparable to tobramycin in PMMA. This finding supports the use of vancomycin in antibiotic-loaded cement. The results suggest that vancomycin may serve as a viable alternative in PMMA. The authors note that the elution profile supports clinical application. They suggest that vancomycin-loaded PMMA could be beneficial in resistant infections. The study provides evidence for further clinical evaluation.
Vancomycin-loaded PMMA may be useful in treating gram-positive sepsis when standard antibiotics fail.